Hormone therapy before surgery may guide radiation decisions in older breast cancer patients
NCT ID NCT04272801
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether taking hormone therapy for 3 months before breast cancer surgery helps women aged 65 and older decide if they want radiation after surgery. The goal is to see if the experience of taking the pills changes their preference. The study does not test a new treatment but gathers information to guide future decisions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER FEMALE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Virginia
Charlottesville, Virginia, 22908, United States
-
Virginia Commonwealth University Massey Cancer Center
Richmond, Virginia, 23298, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can early sexual health counseling transform breast cancer recovery?
- Can a smart drug cross the Blood-Brain barrier to attack breast cancer metastases?
- Can a drug cocktail cure metastatic breast cancer? a trial aims to find out
- What helps or hinders a breast cancer referral? a study listens to Women's stories
- Heating up tumors: could thermal therapy boost immune attack on breast cancer?
- Hypnosis may ease Chemotherapy's toll on breast cancer patients